Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

Prachanna followed by Chirabilwa lepa is more effective for alopecia areata than Prachanna followed by Gunja lepa.

Alopecia areata and psoriasis vulgaris can inhibit each other in the same areas.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Body structure can help identify alopecia areata in Ukrainian men, but not predict its course.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Homeopathic treatment can help manage alopecia areata in children.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Herbal remedies might help with hair loss but need more research for safety and effectiveness.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Four genes are linked to alopecia areata, with two increasing risk and two offering protection.

Understanding and treating alopecia areata improves patient care.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.